Moffitt Cancer Center is looking to recruit and treat 240 men and evaluate safety and effectiveness of Polyphenon E, a drug developed from green tea, in preventing the progression of early signs of prostate cancer. The goal is to also assess if Polyphenon E reduces urinary tract symptoms that men experience with this condition. In July, a team of physicians and scientists, led by Nagi Kumar, Ph.D. [click link for full article]
(more...)